ARK Genomic Revolution EFT

Cathie Wood’s ARK Genomic Revolution EFT has been making big investments in the psychedelics sector since February 2022, most notably in Atai Life Sciences (NASDAQ: ATAI). The fund has now gone deeper and released an extensive report exploring “the therapeutic merits”...

Atai Life Sciences N.V. (NASDAQ: ATAI) recently filed a registration statement with the Securities and Exchange Commission for capital raise of up to $300 million through the issuance of common shares, debt securities, warrants and units. As explained by Jason Najum on Microdose, by using a...